These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1046 related items for PubMed ID: 17350315

  • 1. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P, Bussières L, Chevret S, Bernard JP, Malagrida L, Cuckle H, Chabry C, Durand-Zaleski I, Bidat L, Lacroix I, Moulis M, Roger M, Jacquemot MC, Bault JP, Boukobza P, Boccara P, Vialat F, Giudicelli Y, Ville Y.
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [Abstract] [Full Text] [Related]

  • 2. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population.
    Rozenberg P, Bussières L, Chevret S, Bernard JP, Malagrida L, Cuckle H, Chabry C, Durand-Zaleski I, Bidat L, Lacroix I, Moulis M, Roger M, Jacquemot MC, Bault JP, Boukobza P, Boccara P, Vialard F, Giudicelli Y, Ville Y.
    Am J Obstet Gynecol; 2006 Nov; 195(5):1379-87. PubMed ID: 16723105
    [Abstract] [Full Text] [Related]

  • 3. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, Bianchi DW, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [Abstract] [Full Text] [Related]

  • 4. First- and second-trimester evaluation of risk for Down syndrome.
    Ball RH, Caughey AB, Malone FD, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Emig D, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.
    Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
    [Abstract] [Full Text] [Related]

  • 5. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium.
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [Abstract] [Full Text] [Related]

  • 6. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
    Biggio JR, Morris TC, Owen J, Stringer JS.
    Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
    [Abstract] [Full Text] [Related]

  • 7. First-trimester or second-trimester screening, or both, for Down's syndrome.
    Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME, First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium.
    N Engl J Med; 2005 Nov 10; 353(19):2001-11. PubMed ID: 16282175
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for Down syndrome.
    Kott B, Dubinsky TJ.
    J Am Coll Radiol; 2004 Jun 10; 1(6):415-21. PubMed ID: 17411619
    [Abstract] [Full Text] [Related]

  • 9. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O.
    Ultrasound Obstet Gynecol; 2005 Mar 10; 25(3):221-6. PubMed ID: 15736186
    [Abstract] [Full Text] [Related]

  • 10. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ, Dickinson JE, O'Leary P, Bower C, Goldblatt J, Hewitt B, Murch A, Stock R.
    Aust N Z J Obstet Gynaecol; 2008 Dec 10; 48(6):529-35. PubMed ID: 19133038
    [Abstract] [Full Text] [Related]

  • 11. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R, Cuckle H, Jones R, Reish O, Sharony R, Herman A.
    Prenat Diagn; 2005 Dec 10; 25(12):1102-6. PubMed ID: 16231324
    [Abstract] [Full Text] [Related]

  • 12. Does vaginal bleeding influence first-trimester markers for Down syndrome?
    Heinig J, Steinhard J, Schmitz R, Nofer JR, Witteler R, Mosel A, Ahrens A, Kiesel L, Klockenbusch W.
    Prenat Diagn; 2007 Apr 10; 27(4):312-6. PubMed ID: 17286311
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Three-stage contingent screening for Down syndrome.
    Wright D, Bradbury I, Cuckle H, Gardosi J, Tonks A, Standing S, Benn P.
    Prenat Diagn; 2006 Jun 10; 26(6):528-34. PubMed ID: 16634118
    [Abstract] [Full Text] [Related]

  • 15. Sequential pathways of testing after first-trimester screening for trisomy 21.
    Platt LD, Greene N, Johnson A, Zachary J, Thom E, Krantz D, Simpson JL, Silver RK, Snijders RJ, Goetzl L, Pergament E, Filkins K, Mahoney MJ, Hogge WA, Wilson RD, Mohide P, Hershey D, MacGregor S, Bahado-Singh R, Jackson LG, Wapner R, First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group.
    Obstet Gynecol; 2004 Oct 10; 104(4):661-6. PubMed ID: 15458882
    [Abstract] [Full Text] [Related]

  • 16. A cost-effectiveness analysis of prenatal screening strategies for Down syndrome.
    Odibo AO, Stamilio DM, Nelson DB, Sehdev HM, Macones GA.
    Obstet Gynecol; 2005 Sep 10; 106(3):562-8. PubMed ID: 16135588
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA, Peterson CJ, French CA, Saller DN, Arvan DA.
    Obstet Gynecol; 1994 Aug 10; 84(2):298-303. PubMed ID: 7518896
    [Abstract] [Full Text] [Related]

  • 18. Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation.
    Bahado-Singh RO, Oz AU, Gomez K, Hunter D, Copel J, Baumgarten A, Mahoney MJ.
    Ultrasound Obstet Gynecol; 2000 Mar 10; 15(3):199-204. PubMed ID: 10846774
    [Abstract] [Full Text] [Related]

  • 19. Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: a validation study.
    Palomaki GE, Wright DE, Summers AM, Neveux LM, Meier C, O'donnell A, Huang T, Knight GJ, Haddow JE.
    Prenat Diagn; 2006 Aug 10; 26(8):730-9. PubMed ID: 16810709
    [Abstract] [Full Text] [Related]

  • 20. Comparison of first-trimester contingent screening strategies for Down syndrome.
    Sahota DS, Leung TY, Chan LW, Law LW, Fung TY, Chen M, Lau TK.
    Ultrasound Obstet Gynecol; 2010 Mar 10; 35(3):286-91. PubMed ID: 20052660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.